StockNews.com Initiates Coverage on NeuroMetrix (NASDAQ:NURO)

Analysts at StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research report issued to clients and investors on Monday. The brokerage set a “sell” rating on the medical device company’s stock.

NeuroMetrix Stock Up 0.5 %

NURO opened at $3.71 on Monday. The firm has a market cap of $7.46 million, a price-to-earnings ratio of -0.59 and a beta of 2.30. NeuroMetrix has a 52 week low of $2.70 and a 52 week high of $7.94. The business’s 50 day moving average is $3.86 and its two-hundred day moving average is $3.73.

NeuroMetrix (NASDAQ:NURO) last released its quarterly earnings results on Wednesday, May 15th. The medical device company reported ($1.67) EPS for the quarter. The firm had revenue of $1.09 million for the quarter. NeuroMetrix had a negative return on equity of 39.85% and a negative net margin of 151.51%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NeuroMetrix stock. Cerity Partners LLC bought a new stake in NeuroMetrix, Inc. (NASDAQ:NURO) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned about 2.80% of NeuroMetrix at the end of the most recent quarter. Institutional investors own 19.40% of the company’s stock.

NeuroMetrix Company Profile

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.